Randomised clinical trial of intravenous infusion of umbilical cord mesenchymal stem cells on cardiopathy (RIMECARD)
Overview:
This trial aims to evaluate the use of stem cells from umbilical
cord in the treatment of heart failure. The trial is being conducted
at the Universidad de los Andes in Santiago. 30 participants will
have their cardiac function carefully calibrated and recorded three
months prior to the commencement of the trial, and be randomly
assigned into one of two groups. The experimental group will receive
a single intravenous (IV) injection of mesenchymal stem cells that
have been obtained from donated cord blood. The control group will
receive a placebo intravenous injection. Participants will be
monitored for complications and changes in clinical conditions at
three monthly intervals for one year.
Location: Santiago, Chile
Trial design: Safety and efficacy
Status: Recruiting
Find out more